SCIENTURE HOLDINGS, INC.

SCNX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Revenue $2.9M $2.5M $2.9M $1.5M $955.9K
Cost of Revenue $16.4K $189.8K $440.0K $944.1K
Gross Profit $2.9M $2.5M $2.7M $1.1M $11.8K
Gross Margin 100.0% 100.0% 93.5% 70.6% 1.2%
Operating Expenses
Research & Development
SG&A Expense $2.5M $3.5M $2.9M $2.5M $2.1M
Operating Income $395.1K $-1.0M $-137.1K $-1.4M $-2.1M
Operating Margin 13.5% -40.6% -4.7% -95.7% -218.0%
Interest Expense $157.1K $151.5K $119.5K $4.2K $7.3K
Pretax Income
Income Tax Expense
Net Income $289.0K $-2.8M $-1.1M $-2.0M $-2.1M
Net Margin 9.9% -111.2% -38.4% -134.5% -218.8%
EPS (Basic) $0.00 $-0.01 $0.00 $0.00 $0.00
EPS (Diluted) $0.00 $-0.01 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 511.3M 504.7M 501.1M 477.3M 451.3M
Shares Outstanding (Diluted) 545.4M 504.7M 501.1M 477.3M 451.3M
Dividends Per Share
← Newer Page 2 of 2 Older →